Amrutanjan Health Care Limited
Carnelian Asset Management has slipped below the public reporting line at Amrutanjan Health Care Limited, where it previously held a 4.07 percent stake. This shift signifies either a complete exit or a trim below the 1 percent threshold.
A heritage pharmaceutical manufacturer specializing in over-the-counter products across pain management, women's hygiene, and packaged beverages, Amrutanjan Health Care has operated since 1893. The company produces ayurvedic balms and wellness solutions, leveraging traditional formulations combined with modern manufacturing practices. Currently managed by third-generation promoters, it maintains a significant presence in India's consumer health sector while focusing on accessible wellness solutions for Indian households and retail markets.
Mumbai based investment manager founded in 2019 by Vikas Khemani, former chief executive of Edelweiss Securities, together with Manoj Bahety and Swati Khemani. It runs portfolio management services, Category III alternative investment funds and offshore strategies spanning small, mid and large caps. Stock selection follows a proprietary MCO framework that sorts ideas into Magic, meaning companies re-rating on a management change, industry shift or new product, Compounders with durable moats and steady growth, and Opportunistic special situations. This is paired with the forensic accounting work Manoj Bahety is known for through his Analysis Beyond Consensus approach. Its main vehicles include the Structural Shift Fund, which targets the manufacturing and technology cycles, and the Bharat Amritkaal Fund, a long only flexi cap strategy. The firm has also received approval to enter the mutual fund business.
